Amelung Stefanie, Czock David, Thalheimer Markus, Hoppe-Tichy Torsten, Haefeli Walter E, Seidling Hanna M
Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
Cooperation Unit Clinical Pharmacy, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
J Clin Med. 2022 Jul 23;11(15):4285. doi: 10.3390/jcm11154285.
Structured analyses of hospital administrative data may detect potentially preventable adverse drug events (ADE) and therefore are considered promising sources to prevent future harm and estimate cost savings. Whether results of these analyses indeed correspond to ADE that may be preventable in clinical routines needs to be verified. We exemplarily screened all adult inpatients admitted to a German University Hospital (n = 54,032) for International Classification of Diseases-10th revision (ICD-10) diagnoses coding for drug-induced kidney injury (AKI). In a retrospective chart review, we checked the coded adverse events (AE) for inhospital occurrence, causality to drug exposure, and preventability in all identified cases and calculated positive predictive values (ppv). We identified 69 inpatient cases of whom 41 cases (59.4%) experienced the AE in the hospital (ppv-range 0.43-0.80). Causality assessment revealed a rather likely causal relationship between AE and drug exposure in 11 cases (15.9, 11/69, ppv-range 0.17-0.22) whereby preventability measures could be postulated for seven cases (10.1%, 7/69). Focusing on drug-induced AKI, this study exemplarily underlines that ICD-10-code-based ADE prevention efforts are quite limited due to the small identification rate and its high proportion of primarily outpatient events. Furthermore, causality assessment revealed that cases are often too complex to benefit from generic prevention strategies. Thus, ICD-10-code-based calculations might overestimate patient harm and economic losses.
对医院管理数据进行结构化分析可能会发现潜在可预防的药物不良事件(ADE),因此被视为预防未来伤害和估算成本节约的有前景的来源。这些分析结果是否确实与临床常规中可能可预防的ADE相符,仍需验证。我们以德国一家大学医院收治的所有成年住院患者(n = 54,032)为例,筛查了国际疾病分类第十版(ICD - 10)中药物性肾损伤(AKI)的诊断编码。在回顾性病历审查中,我们检查了所有已识别病例中编码的不良事件(AE)在医院内的发生情况、与药物暴露的因果关系以及可预防性,并计算了阳性预测值(ppv)。我们确定了69例住院病例,其中41例(59.4%)在医院经历了AE(ppv范围为0.43 - 0.80)。因果关系评估显示,11例(15.9%,11/69,ppv范围为0.17 - 0.22)的AE与药物暴露之间存在相当可能的因果关系,其中7例(10.1%,7/69)可假定采取预防措施。以药物性AKI为例,本研究强调基于ICD - 10编码的ADE预防措施相当有限,因为识别率低且主要为门诊事件的比例高。此外,因果关系评估表明,病例往往过于复杂,无法从通用预防策略中获益。因此,基于ICD - 10编码的计算可能高估了患者伤害和经济损失。